![](https://investorshub.advfn.com/uicon/529502.png?cb=1651683647)
Thursday, October 13, 2022 4:33:25 PM
Oh wait, none of that actually exsits so we are going by what the press release states.
That's not how it works and why nothing ever happened with HemaX 1 or HemaX II.
Again, many have a hard time understanding how therapies get approved in the USA, and to date, Koos has had ZERO success in getting anything into P1 trials as well as having no biotech or pharma of significance show ANY INTEREST IN WHAT REGEN IS DOING.
One can try to spin the facts to make it seem like they don't exist but at the end of the day, this OTC stock is trading at .006 on light volume with, supposedly, only one person buying up millions of shares.
That's a recipe for disaster.
FACTS are stubborn things
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM